Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0000950123-20-004407
Filing Date
2020-05-11
Accepted
2020-05-11 21:34:54
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 44639
2 GRAPHIC g908774g0511115337613.jpg GRAPHIC 2408
  Complete submission text file 0000950123-20-004407.txt   49014
Mailing Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1
Business Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2834 Pharmaceutical Preparations